NYSE:MET - Metlife Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $47.33 -0.31 (-0.65 %) (As of 05/20/2019 08:38 AM ET)Previous Close$47.64Today's Range$47.04 - $47.8252-Week Range$37.76 - $48.92Volume4.07 million shsAverage Volume4.94 million shsMarket Capitalization$44.98 billionP/E Ratio8.78Dividend Yield3.72%Beta1.21 ProfileAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners', and personal excess liability, as well as small business owners' property, liability, and business interruption insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against costs of long-term health care services. The company serves individuals, corporations and their employees, and other institutions and their members through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and sponsoring organizations and affinity groups, as well as through career and independent agencies, bancassurance, direct marketing and e-commerce, brokers, and other third-party distribution channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York. Receive MET News and Ratings via Email Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Life insurance Sub-IndustryLife & Health Insurance SectorFinance Current SymbolNYSE:MET Previous Symbol CUSIP59156R10 CIK1099219 Webwww.metlife.com Phone212-578-9500Debt Debt-to-Equity Ratio0.24 Current Ratio0.14 Quick Ratio0.14Price-To-Earnings Trailing P/E Ratio8.78 Forward P/E Ratio8.44 P/E Growth1 Sales & Book Value Annual Sales$67.94 billion Price / Sales0.66 Cash Flow$5.1446 per share Price / Cash Flow9.20 Book Value$61.81 per share Price / Book0.77Profitability EPS (Most Recent Fiscal Year)$5.39 Net Income$5.12 billion Net Margins7.56% Return on Equity10.20% Return on Assets0.79%Miscellaneous Employees48,000 Outstanding Shares950,370,000Market Cap$44.98 billion Next Earnings Date8/7/2019 (Estimated) OptionableOptionable Metlife (NYSE:MET) Frequently Asked Questions What is Metlife's stock symbol? Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET." How often does Metlife pay dividends? What is the dividend yield for Metlife? Metlife announced a quarterly dividend on Tuesday, April 23rd. Stockholders of record on Tuesday, May 7th will be paid a dividend of $0.44 per share on Thursday, June 13th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 3.72%. The ex-dividend date of this dividend is Monday, May 6th. This is an increase from Metlife's previous quarterly dividend of $0.42. View Metlife's Dividend History. How will Metlife's stock buyback program work? Metlife announced that its Board of Directors has authorized a share buyback plan on Thursday, November 1st 2018, which authorizes the company to buyback $2,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 4.6% of its stock through open market purchases. Stock buyback plans are often a sign that the company's board of directors believes its stock is undervalued. How were Metlife's earnings last quarter? Metlife Inc (NYSE:MET) released its earnings results on Wednesday, May, 1st. The financial services provider reported $1.48 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.30 by $0.18. The financial services provider earned $15.45 billion during the quarter, compared to the consensus estimate of $15.95 billion. Metlife had a return on equity of 10.20% and a net margin of 7.56%. Metlife's quarterly revenue was up 2.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.36 EPS. View Metlife's Earnings History. When is Metlife's next earnings date? Metlife is scheduled to release their next quarterly earnings announcement on Wednesday, August 7th 2019. View Earnings Estimates for Metlife. What price target have analysts set for MET? 12 brokers have issued twelve-month price targets for Metlife's stock. Their predictions range from $44.06 to $63.00. On average, they expect Metlife's share price to reach $53.0964 in the next year. This suggests a possible upside of 12.2% from the stock's current price. View Analyst Price Targets for Metlife. What is the consensus analysts' recommendation for Metlife? 12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 6 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Metlife. What are Wall Street analysts saying about Metlife stock? Here are some recent quotes from research analysts about Metlife stock: 1. According to Zacks Investment Research, "MetLife has been performing significantly well on the back of prudent underwriting and expense management. Its efforts to streamline business, only to focus on core business are really impressive. Its revenues grew in 2017 and first half of 2018 after declining for two years and the trend is likely to continue. Its strong international operations and disciplined capital management should drive long-term growth. Its shares have outperformed its industry in six months time. However, the company’s exposure to catastrophe losses and investment in efficiency programs will put pressure on margins. Shares of the company have lost in a year’s time, slightly narrower than its industry’s decline." (1/21/2019) 2. Wells Fargo & Co analysts commented, "We attended in Tokyo. The company provided context around its Asian business, which represents 25% of its earnings ($1.2 billion in 2017) but is expected to grow in the double-digits. Of its Asian business about 75% of its earnings comes from Japan. MET spoke optimistically about: (1) the growth prospects of the region due to its low insurance penetration, GDP growth of 4.8% in the countries MET operates in, and an aging population, and (2) its commitment to sustainable growth in cash from its Asian business (60% of its GAAP earnings are being taken out as dividends). The meeting also gave us a chance to hear from Kishore Ponnavolu, who took over as head of MET’s Asian business at the start of September. We are not changing our EPS estimates or price target at this time and do not expect a material movement in the shares following the meeting." (9/27/2018) Has Metlife been receiving favorable news coverage? Headlines about MET stock have trended positive this week, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Metlife earned a news sentiment score of 2.3 on InfoTrie's scale. They also assigned news headlines about the financial services provider a news buzz of 9.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near term. Are investors shorting Metlife? Metlife saw a decline in short interest during the month of April. As of April 15th, there was short interest totalling 8,334,550 shares, a decline of 40.5% from the March 29th total of 14,008,607 shares. Based on an average daily volume of 4,588,071 shares, the short-interest ratio is currently 1.8 days. Approximately 1.0% of the company's stock are short sold. View Metlife's Current Options Chain. Who are some of Metlife's key competitors? Some companies that are related to Metlife include China Life Insurance (LFC), AXA (AXAHY), Prudential Public (PUK), Prudential Financial (PRU), Manulife Financial (MFC), SWISS RE LTD/S (SSREY), Sun Life Financial (SLF), AVIVA PLC/ADR (AVVIY), HANNOVER RUECK/S (HVRRY), Legal & General Group (LGEN), Lincoln National (LNC), AEGON (AEG), Torchmark (TMK), Reinsurance Group of America (RGA) and SONY FINL HOLDI/ADR (SNYFY). What other stocks do shareholders of Metlife own? Based on aggregate information from My MarketBeat watchlists, some companies that other Metlife investors own include General Electric (GE), AT&T (T), Bank of America (BAC), Exxon Mobil (XOM), IBM (IBM), Pfizer (PFE), Gilead Sciences (GILD), Intel (INTC), JPMorgan Chase & Co. (jpm) and Johnson & Johnson (JNJ). Who are Metlife's key executives? Metlife's management team includes the folowing people: Mr. Michel A. Khalaf, CEO, Pres & Director (Age 55)Mr. John Dennis McCallion CPA, Exec. VP & CFO (Age 45)Mr. Steven Jeffrey Goulart, Exec. VP & Chief Investment Officer (Age 60)Ms. Tamara L. Schock C.A., CPA, Exec. VP & Chief Accounting Officer (Age 47)Mr. John Arthur Hall, Sr. VP & Head of Investor Relations Who are Metlife's major shareholders? Metlife's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.51%), FMR LLC (4.56%), Wellington Management Group LLP (3.16%), Geode Capital Management LLC (1.33%), Northern Trust Corp (1.19%) and Diamond Hill Capital Management Inc. (1.12%). Company insiders that own Metlife stock include Carlos M Gutierrez, Christopher G Townsend, Gerald L Hassell, John D Mccallion, Steven A Kandarian and Steven J Goulart. View Institutional Ownership Trends for Metlife. Which major investors are selling Metlife stock? MET stock was sold by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, FMR LLC, BlackRock Inc., Pzena Investment Management LLC, Morgan Stanley, Man Group plc, Wells Fargo & Company MN and Vaughan David Investments LLC IL. Company insiders that have sold Metlife company stock in the last year include John D Mccallion, Steven A Kandarian and Steven J Goulart. View Insider Buying and Selling for Metlife. Which major investors are buying Metlife stock? MET stock was acquired by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Ronna Sue Cohen, MERIAN GLOBAL INVESTORS UK Ltd, AJO LP, Charles Schwab Investment Management Inc., SG Americas Securities LLC, Dana Investment Advisors Inc. and Acadian Asset Management LLC. Company insiders that have bought Metlife stock in the last two years include Carlos M Gutierrez and Gerald L Hassell. View Insider Buying and Selling for Metlife. How do I buy shares of Metlife? Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Metlife's stock price today? One share of MET stock can currently be purchased for approximately $47.33. How big of a company is Metlife? Metlife has a market capitalization of $44.98 billion and generates $67.94 billion in revenue each year. The financial services provider earns $5.12 billion in net income (profit) each year or $5.39 on an earnings per share basis. Metlife employs 48,000 workers across the globe. What is Metlife's official website? The official website for Metlife is http://www.metlife.com. How can I contact Metlife? Metlife's mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider can be reached via phone at 212-578-9500. MarketBeat Community Rating for Metlife (NYSE MET)Community Ranking: 3.0 out of 5 ( )Outperform Votes: 776 (Vote Outperform)Underperform Votes: 503 (Vote Underperform)Total Votes: 1,279MarketBeat's community ratings are surveys of what our community members think about Metlife and other stocks. Vote "Outperform" if you believe MET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MET will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/20/2019 by MarketBeat.com StaffFeatured Article: How to calculate the annual rate of depreciation Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.